Compare CoMentis vs Epiphany Biosciences
Customers evaluate the quality of CoMentis's products using the following success metrics.
Overview
CoMentis is 20 yrs old and is based in United States.
CoMentis is focused on developing drugs to treat various central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company covers the research and development spectrum from initial drug design through manufacturing and clinical trials.
Epiphany Biosciences is 18 yrs old and is based in United States.
Epiphany Biosciences is focused on advancing new therapies for infectious disease. The founders include Fred Volinsky MD, Robert Gallo MD, David Myles Ph.D and Barry Selick Ph.D. Epiphany is located in San Francisco, California.
Demo Video
Leadership
W. Scott Harkonen (Chief Executive Officer, President)
Fred G Volinsky (Chief Executive Officer)
Funding
Investors
Sanderling Ventures, Life Science Angels
CDIB BioScience Venture Management, Medivir
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because CoMentis has not claimed their profile.
Work for CoMentis? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for CoMentis?
Claim your profile now.
Information not available because Epiphany Biosciences has not claimed their profile.
Work for Epiphany Biosciences? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Epiphany Biosciences?
Claim your profile now.